Anthrax countermeasures get US liability protection

Companies that develop and manufacture medical anthrax countermeasures will receive immunity from product liability claims through 2015 under a declaration issued by the US health and human services secretary Michael Leavitt.

More from Anti-infective

More from Therapeutic Category